Systemic Lupus Erythematosus in a Multiethnic Lupus Cohort (LUMINA). XVII. Predictors of Self-reported Health-related Quality of Life Early in the Disease Course
Overview
Authors
Affiliations
Objective: To determine the baseline factors predictive of self-reported health-related quality of life (HRQOL) early in the course of systemic lupus erythematosus patients (SLE) from a multiethnic LUMINA (Lupus in Minorities: Nature versus nurture) cohort.
Methods: LUMINA patients with > or =2 visits were studied. Self-reported HRQOL was examined with the 8 subscales and 2 summary measures (the Physical Component Summary [PCS], and the Mental Component Summary [MCS]) of the Short Form 36 (SF-36). Bivariable and multivariable analyses were done with the PCS, MCS and 8 subscales as the dependent variables. The analyses were performed including and excluding the corresponding SF-36 measure from the independent variables. Age, sex, and ethnicity were included in all models. Time was modeled in all regressions.
Results: A total of 1,351 visits (346 patients [80 Hispanics-Texas, 34 Hispanics-Puerto Rico, 126 African Americans, and 106 Caucasians]) were included in these analyses. Mean +/- SD PCS and MCS scores were 36.7 +/- 12.0 and 46.6 +/- 11.5, respectively. The scores for the eight subscales of the SF-36 were also lower than those for the general population. Baseline SF-36 measures were highly predictive of subsequent HRQOL. In the same set of regressions, older age was found to consistently predict poor self-reported HRQOL whereas fibromyalgia, helplessness, fatigue, and abnormal illness-related behaviors were also predictive, but less consistently. Estimated adjusted variances in these regressions ranged from 23% (Role-Emotional [RE]) to 43% (Physical Functioning [PF]).
Conclusion: In patients with SLE, poor baseline HRQOL was highly predictive of subsequent poor HRQOL. Other predictive variables of poor functioning were primarily psychological/behavioral and socioeconomic-demographic.
Mistry S, Daoud A, Nighat Magrey M, Pamuk O Clin Rheumatol. 2024; 44(1):9-21.
PMID: 39424681 DOI: 10.1007/s10067-024-07188-9.
Aljohani R, Aljanobi G, Alderaan K, Omair M Saudi Med J. 2024; 45(10):1071-1079.
PMID: 39379126 PMC: 11463565. DOI: 10.15537/smj.2024.45.10.20240432.
Tharwat S, Husain S BMC Musculoskelet Disord. 2024; 25(1):272.
PMID: 38589834 PMC: 11003043. DOI: 10.1186/s12891-024-07367-4.
Gawrieh S, Corey K, Lake J, Samala N, Desai A, Debroy P PLoS One. 2023; 18(2):e0279685.
PMID: 36763643 PMC: 9916563. DOI: 10.1371/journal.pone.0279685.
Raghunath S, Guymer E, Glikmann-Johnston Y, Golder V, Kandane Rathnayake R, Morand E Rheumatology (Oxford). 2022; 62(1):190-199.
PMID: 35383358 PMC: 9788827. DOI: 10.1093/rheumatology/keac207.